1. EPWORTH Knowedge Bank
  2. Academic & Clinical
  3. Research Week
Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/1900
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWong, Rachel-
dc.contributor.authorAnanda, Sumitra-
dc.contributor.otherSantucci, Jordan-
dc.contributor.otherLee, Belinda-
dc.contributor.otherTomson, Ben-
dc.contributor.otherMichael, Michael-
dc.contributor.otherShapiro, Julia-
dc.contributor.otherClarke, Kate-
dc.contributor.otherPattison, Sharon-
dc.contributor.otherBurge, Matthew-
dc.contributor.otherZielinski, Rob-
dc.contributor.otherNikfarjam, Mehrdad-
dc.contributor.otherLipton, Lara-
dc.contributor.otherGibbs, Peter-
dc.date.accessioned2020-11-20T01:02:22Z-
dc.date.available2020-11-20T01:02:22Z-
dc.date.issued2020-10-
dc.identifier.urihttp://hdl.handle.net/11434/1900-
dc.description.abstractTo assess whether first-then-second-line treatment sequence wither either FOLFIRINOX or Gem/Nab-P as first-line palliative chemotherapy impacts survival outcomes.en_US
dc.subjectAdvanced Pancreatic Canceren_US
dc.subjectPancreatic Ductal Adenocarcinomaen_US
dc.subjectPDACen_US
dc.subjectGemcitabine Monotherapyen_US
dc.subjectFOLFIRINOXen_US
dc.subjectGem/Nab-Pen_US
dc.subjectPalliative Chemotherapyen_US
dc.subjectSurvival Outcomesen_US
dc.subjectPURPLE registryen_US
dc.subject(Pancreatic cancer – Understanding Routine Practice and Lifting End resultsen_US
dc.subjectChisquare Testen_US
dc.subjectMann-Whitney U Testen_US
dc.subjectKaplan-Meier Methoden_US
dc.subjectBreslow Testen_US
dc.subjectCox Proportional Hazards Regressionen_US
dc.subjectCancer Services Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.titleInvestigating the “real-world” clinical impact of treatment sequencing in advanced pancreatic cancer outcomes: a PURPLE translational registry analysis.en_US
dc.typeConference Posteren_US
dc.description.affiliatesWalter & Eliza Hall Institute (WEHI), Vic, Australiaen_US
dc.description.affiliatesThe Royal Melbourne Hospital, Vic, Australiaen_US
dc.description.affiliatesUniversity of Melbourne, Australiaen_US
dc.description.affiliatesPeter MacCallum Cancer Centre, Vic, Australiaen_US
dc.description.affiliatesNorthern Health, Vic, Australiaen_US
dc.description.affiliatesCabrini Health, Vic, Australiaen_US
dc.description.affiliatesEastern Health, VIC, Australiaen_US
dc.description.affiliatesWellington Hospital, New Zealanden_US
dc.description.affiliatesDunedin University Hospital, New Zealanden_US
dc.description.affiliatesRoyal Brisbane and Women’s Hospital, Qld, Australiaen_US
dc.description.affiliatesOrange and Dubbo Base Hospitals, NSW, Australiaen_US
dc.description.affiliatesAustin Health, Melbourne, Australiaen_US
dc.description.affiliatesWestern Health, Melbourne, Australiaen_US
dc.type.studyortrialRetrospective studiesen_US
dc.description.conferencenameEpworth HealthCare Research Month 2020en_US
dc.description.conferencelocationEpworth Research Institute, Victoria, Australiaen_US
dc.type.contenttypeTexten_US
Appears in Collections:Research Week

Files in This Item:
File Description SizeFormat  
Santucci. Jordan_Epworth Research Month 2020 Poster.pdf3.5 MBAdobe PDFThumbnail
View/Open
Show simple item record


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.